{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:39:12Z","timestamp":1789915152882,"version":"4.0.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T00:00:00Z","timestamp":1573776000000},"content-version":"vor","delay-in-days":2478,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1093\/annonc\/mds504","type":"journal-article","created":{"date-parts":[[2012,10,27]],"date-time":"2012-10-27T01:01:09Z","timestamp":1351299669000},"page":"322-328","source":"Crossref","is-referenced-by-count":29,"title":["Tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumors"],"prefix":"10.1016","volume":"24","author":[{"given":"C.","family":"Massard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kramar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.T.","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lorch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"Pico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Rosti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Droz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Fizazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1093\/annonc\/mds504_bb0010","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.eururo.2007.12.024","article-title":"European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I","volume":"53","author":"Krege","year":"2008","journal-title":"Eur Urol"},{"issue":"6","key":"10.1093\/annonc\/mds504_bb0015","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jama.299.6.672","article-title":"Medical treatment of advanced testicular cancer","volume":"299","author":"Feldman","year":"2008","journal-title":"JAMA"},{"issue":"7","key":"10.1093\/annonc\/mds504_bb0020","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/annonc\/mdi228","article-title":"A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours","volume":"16","author":"Pico","year":"2005","journal-title":"Ann Oncol"},{"issue":"19","key":"10.1093\/annonc\/mds504_bb0025","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1200\/JCO.2006.09.2148","article-title":"Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular Cancer Study Group","volume":"25","author":"Lorch","year":"2007","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1093\/annonc\/mds504_bb0030","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJMoa067749","article-title":"High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors","volume":"357","author":"Einhorn","year":"2007","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1093\/annonc\/mds504_bb0035","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1200\/JCO.2009.25.1561","article-title":"TI-CE high-dose chemotherapy for patients with previously treated germ cell tumors: results and prognostic factor analysis","volume":"28","author":"Feldman","year":"2010","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1093\/annonc\/mds504_bb0040","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1200\/JCO.1997.15.2.594","article-title":"International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group","volume":"15","year":"1997","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1093\/annonc\/mds504_bb0045","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1200\/JCO.2001.19.9.2534","article-title":"Predicting outcome to chemotherapy in patients with germ cell tumors: the value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapy","volume":"19","author":"Mazumdar","year":"2001","journal-title":"J Clin Oncol"},{"issue":"19","key":"10.1093\/annonc\/mds504_bb0050","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1200\/JCO.2004.04.008","article-title":"Early predicted time to normalization of tumor markers predicts outcome in poor-prognosis nonseminomatous germ cell tumors","volume":"22","author":"Fizazi","year":"2004","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1093\/annonc\/mds504_bb0055","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1200\/JCO.2005.05.4528","article-title":"Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors","volume":"25","author":"Motzer","year":"2007","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1093\/annonc\/mds504_bb0060","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1200\/JCO.1998.16.2.725","article-title":"Primary mediastinal nonseminomatous germ cell tumors: results of modern therapy including cisplatin-based chemotherapy","volume":"16","author":"Fizazi","year":"1998","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1093\/annonc\/mds504_bb0065","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1200\/JCO.2002.07.062","article-title":"Extragonadal germ cell tumors of the mediastinum and retroperitoneum: results from an international analysis","volume":"20","author":"Bokemeyer","year":"2002","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1093\/annonc\/mds504_bb0070","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1200\/JCO.2001.19.6.1641","article-title":"Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: results of an international multicenter analysis","volume":"19","author":"Hartmann","year":"2001","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1093\/annonc\/mds504_bb0075","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1093\/annonc\/mdf176","article-title":"Prognostic variables for response and outcome in patients with extragonadal germ-cell tumors","volume":"13","author":"Hartmann","year":"2002","journal-title":"Ann Oncol"},{"issue":"27","key":"10.1093\/annonc\/mds504_bb0080","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1200\/JCO.2005.19.638","article-title":"Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors","volume":"23","author":"Kondagunta","year":"2005","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1093\/annonc\/mds504_bb0085","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1200\/JCO.2006.06.9401","article-title":"Paclitaxel plus Ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors","volume":"25","author":"Kondagunta","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds504_bb0090","unstructured":"K Fizazi G Gravis A Flechon. A prospective multicenter GETUG phase II trial of gemcitabine, cisplatin, and ifosfamide (GIP) in patients with relapsed metastatic germ-cell tumors (GCT)Abstract 8690, ESMO Meeting 2010"},{"issue":"15s","key":"10.1093\/annonc\/mds504_bb0095","article-title":"A phase II trial of high-dose chemotherapy (HDCT) supported by haematopoietic stem cell transplantation (HSCT) in patients (pts) with disseminated germ-cell tumors (GCTs) failing chemotherapy and with adverse prognostic factors: The TAXIF II protocol","volume":"27","author":"Lotz","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds504_bb0100","doi-asserted-by":"crossref","first-page":"374","DOI":"10.7150\/jca.2.374","article-title":"Is high dose therapy superior to conventional dose therapy as initial treatment for relapsed germ cell tumors? The TIGER Trial","volume":"2","author":"Feldman","year":"2011","journal-title":"J Cancer"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419368796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419368796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/24\/2\/322\/602900\/mds504.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T07:32:26Z","timestamp":1624692746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419368796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0923753419368796"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mds504","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}